to work primarily on mAbs for Malaria, a disease which disproportionately impacts the developing world, and COVID-19 mAbs

Grant number: INV-004259

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
  • Known Financial Commitments (USD)

    $1,310,303
  • Funder

    Gates Foundation
  • Research Location

    United States of America
  • Lead Research Institution

    Curia Bio, Inc.
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation
  • Research Subcategory

    Pre-clinical studies
  • Special Interest Tags

    N/A
  • Study Type

    Non-Clinical
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Not Applicable
  • Vulnerable Population

    Not applicable
  • Occupations of Interest

    Not applicable

Abstract

N/A